Company Profile
Orthocell Limited, a regenerative medicine company develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia and globally.
It offers Ortho Autologous Chondrocyte Implantation, a cartilage cell therapy for treatment of articular cartilage defects in the knee and ankle. Its portfolio also includes Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental applications, and Remplir, a collagen scaffold used in peripheral nerve repair.
It also develops Collagen Medical Device platform products for nerve, tendon, and ligament repair; and Tendon Cell Therapy for rotator cuff and lateral epicondyle indications. Incorporated in 2006, Orthocell is headquartered in Murdoch, Australia.